First phase in HIV vaccine project is completed

This article is reproduced by CienciaPR with permission from the original source.

PDF versionPDF version

CienciaPR Contribution: 



Keila López Alicea
El profesor Eduardo Nicolau y la estudiante doctoral Perla Curz Toro trabajan en la investigación para desarrollar membranas para filtrar orina, proyecto por el cual el joven recibió una beca NASA ASTAR. (Luis Alcalá del Olmo)

The University of Puerto Rico (UPR) is actively engaged in the race to develop a vaccine against HIV. In just 18 month, researchers from the Molecular Sciences Research Center at UPR have succesfully completed the first phase of a project to develop an HIV vaccine and are waiting for NIH aproval to begin the second phase. 

For the full article, please refer to the spanish version of this site. 



Content Categories: